John Varian
Chief Financial Officer, ARYx Therapeutics, Inc.
Companies
- Galena BiopharmaBoard member Dec 29, 2017 to now1
- Acorda TherapeuticsBoard member Jan 4, 2022 to Jun 23, 20232
- Aravive, Inc.Board member Mar 20, 2014 to Dec 22, 20173
- XOMA Royalty CorpBoard member Dec 10, 2008 to May 22, 20174
- XOMA Royalty CorpChief executive officer Oct 28, 2011 to Mar 22, 20165
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Galena Biopharma SLS72,900 shares6$826.7K at $11.34Jan 7, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jan 7, 2026Granted 50,000 shares of Galena Biopharma6
- Jan 10, 2025Granted 12,500 shares of Galena Biopharma7
- Jan 22, 2024Granted 6,000 shares of Galena Biopharma8
- Feb 2, 2023Granted 2,500 shares of Galena Biopharma9
- Jan 31, 2022Granted 1,900 shares of Galena Biopharma10
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARGalena Biopharma, Board member
- 2SEC EDGARAcorda Therapeutics, Board member
- 3SEC EDGARAravive, Inc., Board member
- 4SEC EDGARXOMA Royalty Corp, Board member
- 5
- 6
- 7SEC EDGARForm 4 filed Jan 14, 2025
- 8SEC EDGARForm 4 filed Jan 25, 2024
- 9SEC EDGARForm 4 filed Feb 3, 2023
- 10SEC EDGARForm 4 filed Feb 1, 2022